Add To Watchlist

ZYPREXA

The Wire

Conn. gets $25 million from Zyprexa lawsuit

Connecticut officials say Eli Lilly & Co. has agreed to a $25 million settlement with the state over claims the drugmaker marketed its anti-psychotic drug Zyprexa for unapproved uses and harmed patients.

Lilly settles Zyprexa suit for $1.42 billion

Eli Lilly & Co. taught its sales force a catchy slogan to peddle the antipsychotic drug Zyprexa for treating the elderly.

Lilly nears $1.4B Zyprexa agreement, report says

Drugmaker Eli Lilly and Co. is close to agreeing to a $1.4 billion settlement related to a government investigation into the marketing of its top seller Zyprexa, according to a New York Times report.

Lilly takes $1.4B charge related to investigation

Eli Lilly and Co. will take a big bite out of its third-quarter earnings with a $1.4 billion charge related to a government investigation over marketing practices for the anti-psychotic Zyprexa.

Judge urges Eli Lilly to settle Zyprexa lawsuit

A federal judge in New York is urging Eli Lilly and Co. to settle a multibillion-dollar lawsuit filed by insurance companies, unions and others who claim the pharmaceutical giant overpriced its top-selling drug Zyprexa and exaggerated its usefulness.

Lilly Settles Alaska Suit Over Zyprexa

Eli Lilly and Co. and Alaska announced a $15 million settlement Wednesday in the state's lawsuit over the use of the drug Zyprexa in its Medicaid program.

State: No Alerts on Zyprexa Side Effects

Eli Lilly and Co. failed to adequately warn doctors and patients of dangerous side effects associated with its drug Zyprexa, an attorney for Alaska said Wednesday in opening arguments in the state's lawsuit against the drug maker.

Shareholders Sue Lilly Over Zyprexa Woes

Eli Lilly and Co. has paid more than $1 billion to settle legal battles over its top-selling drug Zyprexa, and it might have to write another large check soon. But a new lawsuit says the company should have known better.

Report: Lilly, Govt Explore Zyprexa Deal

Eli Lilly and Co. and federal prosecutors are exploring a settlement of an investigation into the drugmaker's marketing of its top seller, the anti-psychotic Zyprexa, The New York Times reported Wednesday.

The Vine
Former Lily Rep Claims Bribery Used as Marketing Strategy
Source: YouTube

Dr John Rengen Virapen, Whistleblower of the Psychopathic Pharmaceutical Industry, Speaks Out

CVS / Lilly in sweetheart deal marketing Zyprexa to insurers
Source: The Boston Globe

A CVS subsidiary offered to send 120,000 letters to doctors promoting Zyprexa - at a charge of $5 per letter. A unit of CVS Caremark Corp.

Lilly Sold Drug for Dementia Knowing It Didn't Help, Files Show
Source: Bloomberg.com

June 12 (Bloomberg) -- Eli Lilly & Co.

Children's Use Of Psychiatric Drugs Begins To Decelerate
Source: Wall Street Journal

"The growth in antipsychotic-drug prescriptions for children is slowing," and for young children the number of prescriptions is apparently actually decreasing.

A Grim Truth About Big Pharma
Source: new york times

Last month the New York Times exposed yet another example of unethical marketing practices by pharmaceutical giant Eli Lilly.

Fox, Douglas Kennedy, Lilly pays $1.42 billion in Zyprexa suit
Source: YouTube

Finally Eli Lilly pleads guilty to mislabeling Zyprexa drug to sell it to a wider market.

Heart risk cited in newer antipsychotic drugs
Source: The L.A. Times

Zyprexa, Risperdal and Seroquel, among the 10 most commonly prescribed medications, are just as likely as older antipsychotic drugs to cause a fatal heart attack, a study finds.

Eli Lilly Owes $1.4B Over "Off Label" Use
Source: CBS News

Eli Lilly has pled guilty to marketing the sometimes dangerous drug Zyprexa in ways never proven safe or effective. The company will be fined $1.4 billion reckless behavior.

Eli Lilly Settles Zyprexa Case With States for $62 Million
Source: The New York Times

Eli Lilly has agreed to pay $62 million to 33 states to settle claims that it improperly marketed Zyprexa, its top-selling drug, to patients who did not have schizophrenia or bipolar disorder, its only approved uses.

Lechleiter takes Lilly Top Job
Source: CNN

Lechleiter inherits the biggest problem facing Big Pharma today: beefing up the pipeline in the face of disappearing blockbusters.

Dementia relief, with a huge side effect
Source:

Two years ago, federal regulators sounded a dire warning: Elderly people with dementia who take drugs like Seroquel, Risperdal and Zyprexa could suffer the ultimate side effect. They could die.

Documents Borne by Winds of Free Speech
Source: The New York Times

A showdown is scheduled for a federal courtroom in Brooklyn tomorrow afternoon, where words like First Amendment and freedom of speech and prior restraint are likely to mix seamlessly with references to BitTorrent and Wiki.

Drug Company Suppressed $4.2 Billion Schizophrenia Drug's Dangers
Source: MarketWatch.com

TEL AVIV (MarketWatch) - Eli Lilly & Co.

School kids on drugs (prescription)
Source: Independent news on natural health, nutrition and more

My issue is Zyprexa which is only FDA approved for schizophrenia (.5-1% of pop) and some bipolar (2% pop) and then an even smaller percentage of theses two groups. So how does Zyprexa get to be the 7th largest drug sale in the world? Eli Lilly is in deep trouble for using th …

This area needs news. Click here to seed the vine